Subscribe
shutterstock_1857404794_michael_vi
Michael Vi / Shutterstock.com
2 February 2021GeneticsAlex Baldwin

Illumina wins PTAB appeal over Columbia DNA patents

Biotech company Illumina has won a dispute with Columbia University, after the Court of Appeals for the Federal Circuit backed an earlier ruling that the university’s DNA-sequencing patents were invalid.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
BGI counter sues Illumina for patent infringement
4 October 2019   A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina.
Americas
Federal Circuit affirms invalidation of two Illumina patents
1 February 2016   The US Court of Appeals for the Federal Circuit has knocked out two patents belonging to biotechnology company Illumina following a challenge by Intelligent Bio-Systems.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Big Pharma
BGI counter sues Illumina for patent infringement
4 October 2019   A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina.
Americas
Federal Circuit affirms invalidation of two Illumina patents
1 February 2016   The US Court of Appeals for the Federal Circuit has knocked out two patents belonging to biotechnology company Illumina following a challenge by Intelligent Bio-Systems.

More on this story

Big Pharma
BGI counter sues Illumina for patent infringement
4 October 2019   A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina.
Americas
Federal Circuit affirms invalidation of two Illumina patents
1 February 2016   The US Court of Appeals for the Federal Circuit has knocked out two patents belonging to biotechnology company Illumina following a challenge by Intelligent Bio-Systems.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent